glimepiride 2 MG / pioglitazone 30 MG Oral Tablet

Known as: glimepiride 2 MG / pioglitazone (as pioglitazone hydrochloride) 30 MG Oral Tablet, GLIMEPIRIDE 2MG/PIOGLITAZONE HCL 30MG TAB, GLIMEPIRIDE 2MG/PIOGLITAZONE HCL 30MG TAB [VA Product] 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1993-2016
01219932016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
OBJECTIVE To evaluate the efficacy and safety of adding the once-weekly DPP-4 inhibitor omarigliptin or the sulfonylurea… (More)
Is this relevant?
2016
2016
BACKGROUND The 52-week monotherapy with the dipeptidyl peptidase-4 inhibitor sitagliptin and the sulphonylurea glimepiride on… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2016
2016
A rapid and sensitive ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS-MS) method for the simultaneous… (More)
Is this relevant?
2015
2015
AIM AND OBJECTIVE The aim was to evaluate and compare the efficacy and safety of combinations of metformin-vidagliptin (MF-VG… (More)
Is this relevant?
Highly Cited
2014
Highly Cited
2014
BACKGROUND Metformin is the recommended first-line pharmacotherapy for patients with type 2 diabetes. There is no consensus on… (More)
Is this relevant?
2010
2010
BACKGROUND In 2005, a fixed-dose combination therapy (FDCT) of rosiglitazone maleate and glimepiride became available for… (More)
Is this relevant?
2009
2009
The phenomenon termed postconditioning, that is, brief episodes of ischemia/reperfusion at the onset of reperfusion reduce… (More)
  • figure 1
  • table 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
2004
2004
AIM To study the pharmaceutical characterization, the pharmacokinetics and relative bioavailability of glimepiride gel-matrix… (More)
Is this relevant?
2002
2002
BACKGROUND To investigate whether the sulfonylurea glimepiride affects the myoprotective effects of ischemic preconditioning (IPC… (More)
Is this relevant?
1996
1996
Glimepiride is a new generation sulphonylurea being prudently characterized in more than 2000 NIDDM patients. It has a short… (More)
Is this relevant?